Literature DB >> 19189093

Perflubron residua: 12 years following therapy.

Sabah Servaes1, Monica Epelman.   

Abstract

Partial liquid ventilation therapy utilizing perfluorocarbons has been used for patients with severe respiratory distress. Perfluorocarbons such as perflubron have been demonstrated to clear from the lungs shortly after therapy. We present a 13-year-old boy with residual perflubron in his lungs, 12 years following therapy with perflubron. The imaging features are important to recognize as these patients return for additional care and imaging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189093     DOI: 10.1007/s00247-008-1139-8

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

Review 1.  Liquid ventilation.

Authors:  T H Shaffer; M R Wolfson; L C Clark
Journal:  Pediatr Pulmonol       Date:  1992-10

Review 2.  Partial liquid ventilation.

Authors:  Mark C K Hamilton; Giles J Peek; Anthony E W Dux
Journal:  Pediatr Radiol       Date:  2005-09-09

3.  Radiographic detection of perflubron fluoromediastinum and fluororetroperitoneum 9 years after partial liquid ventilation.

Authors:  R Daniel Hagerty; Michael P Phelan; Stuart C Morrison; Stephen F Hatem
Journal:  Emerg Radiol       Date:  2007-10-31

4.  Acute respiratory distress syndrome: CT findings during partial liquid ventilation.

Authors:  J F Meaney; E A Kazerooni; K A Garver; R B Hirschl
Journal:  Radiology       Date:  1997-02       Impact factor: 11.105

5.  Liquid ventilation of preterm baby.

Authors:  J S Greenspan; M R Wolfson; S D Rubenstein; T H Shaffer
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

6.  Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group.

Authors:  C L Leach; J S Greenspan; S D Rubenstein; T H Shaffer; M R Wolfson; J C Jackson; R DeLemos; B P Fuhrman
Journal:  N Engl J Med       Date:  1996-09-12       Impact factor: 91.245

7.  Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans.

Authors:  R F Mattrey; P C Hajek; V M Gylys-Morin; L L Baker; J Martin; D C Long; D M Long
Journal:  AJR Am J Roentgenol       Date:  1987-06       Impact factor: 3.959

8.  Partial liquid ventilation with perflubron during extracorporeal life support in adults: radiographic appearance.

Authors:  E A Kazerooni; T Pranikoff; P N Cascade; R B Hirschl
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

  8 in total
  4 in total

1.  'Pseudo-calcifications': detection of perfluorocarbon residue on a computed tomography scan 15 years after liquid ventilation therapy at 3 months of age.

Authors:  Sameem Tak; Mary Barraclough
Journal:  BMJ Case Rep       Date:  2018-03-05

Review 2.  Administration of Drugs/Gene Products to the Respiratory System: A Historical Perspective of the Use of Inert Liquids.

Authors:  Deepthi Alapati; Thomas H Shaffer
Journal:  Front Physiol       Date:  2022-05-10       Impact factor: 4.755

Review 3.  Perfluorocarbon Emulsion Contrast Agents: A Mini Review.

Authors:  Ryan Holman; Orane Lorton; Pauline C Guillemin; Stéphane Desgranges; Christiane Contino-Pépin; Rares Salomir
Journal:  Front Chem       Date:  2022-01-10       Impact factor: 5.221

4.  Liquid fluorocarbon lavage to clear thrombus from the distal airways after severe pulmonary hemorrhage requiring extracorporeal life support (ECLS).

Authors:  Christopher M Horvat; Joseph A Carcillo; Cameron Dezfulian
Journal:  Respir Med Case Rep       Date:  2015-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.